We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.15%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$105B
AUM Growth
-$28.9B
(-22%)
Cap. Flow
-$16.6B
Cap. Flow
% of AUM
-15.73%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
2,544
New
149
Increased
755
Reduced
1,080
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$348M |
| 2 |
American Tower
AMT
|
+$230M |
| 3 |
SOLN
The Southern Company
SOLN
|
+$211M |
| 4 |
Avantor
AVTR
|
+$196M |
| 5 |
SLB Ltd
SLB
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$373M |
| 2 |
Freeport-McMoran
FCX
|
+$359M |
| 3 |
Deere & Co
DE
|
+$303M |
| 4 |
AVTR.PRA
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
|
+$251M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.75% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 7.5% |
| 5 | Communication Services | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
CALL
Crown Castle
CCI
$32.2B
| $808K | ﹤0.01% |
4,800
+2,000
| +71% | +$364K |
|
1602
Karyopharm Therapeutics
KPTI
$48M
| $808K | ﹤0.01% |
11,948
+1,016
| +9% | +$93.2K |
|
1603
Prospect Capital
PSEC
$1.17B
| $804K | ﹤0.01% |
114,942
-4,412
| -4% | -$33.9K |
|
1604
Archrock
AROC
$5.8B
| $803K | ﹤0.01% |
97,049
| – | – |
|
1605
Guidewire Software
GWRE
$14.2B
| $801K | ﹤0.01% |
+11,287
| New | +$923K |
|
1606
Malibu Boats
MBUU
$567M
| $799K | ﹤0.01% |
15,153
-12,541
| -45% | -$681K |
|
1607
Zions Bancorporation
ZION
$10.3B
| $795K | ﹤0.01% |
+15,615
| New | +$887K |
|
1608
Webster Financial
WBS
$12.8B
| $789K | ﹤0.01% |
+18,712
| New | +$901K |
|
1609
Flowers Foods
FLO
$1.57B
| $785K | ﹤0.01% |
29,836
-9,779
| -25% | -$257K |
|
1610
CALL
Gilead Sciences
GILD
$165B
| $785K | ﹤0.01% |
12,700
-25,700
| -67% | -$1.59M |
|
|
LILMW
1611
DELISTED
Lilium N.V. Warrants
LILMW
| $783K | ﹤0.01% |
2,853,997
+1,088,997
| +62% | +$467K |
|
1612
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $781K | ﹤0.01% |
+8,260
| New | +$818K |
|
1613
PUT
T-Mobile US
TMUS
$190B
| $780K | ﹤0.01% |
5,800
-16,400
| -74% | -$2.14M |
|
1614
Terex
TEX
$7.74B
| $777K | ﹤0.01% |
28,365
-37,033
| -57% | -$1.23M |
|
1615
The Ensign Group
ENSG
$10.7B
| $776K | ﹤0.01% |
10,565
-1,097
| -9% | -$87.5K |
|
1616
PUT
Lockheed Martin
LMT
$136B
| $774K | ﹤0.01% |
1,800
-14,100
| -89% | -$6.19M |
|
|
CSGS
1617
DELISTED
CSG Systems International
CSGS
| $773K | ﹤0.01% |
+12,946
| New | +$784K |
|
1618
PJT Partners
PJT
$4.38B
| $770K | ﹤0.01% |
10,957
-2,013
| -16% | -$140K |
|
|
NARI
1619
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $767K | ﹤0.01% |
11,275
-598
| -5% | -$43K |
|
|
MRSH
1620
PUT
Marsh
MRSH
$91.5B
| $761K | ﹤0.01% |
4,900
-1,200
| -20% | -$192K |
|
1621
Huntsman Corp
HUN
$1.77B
| $760K | ﹤0.01% |
26,818
-187,578
| -87% | -$6.33M |
|
1622
Olin
OLN
$2.12B
| $752K | ﹤0.01% |
16,246
-207,212
| -93% | -$12M |
|
1623
Qiagen
QGEN
$8.72B
| $750K | ﹤0.01% |
+14,977
| New | +$731K |
|
1624
Otter Tail
OTTR
$3.94B
| $748K | ﹤0.01% |
11,142
-6,394
| -36% | -$406K |
|
1625
Kymera Therapeutics
KYMR
$8.94B
| $747K | ﹤0.01% |
37,930
-2,440
| -6% | -$57K |
|
Similar funds
Allianz Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Allianz Asset Management held 2,544 positions worth $105B, down 22% from $134B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Allianz Asset Management withdrew a net $16.6B in Q2 2022, closing 294 positions and reducing 1,080 holdings. Its most notable exit was Avantor, Inc. Series A Mandatory Convertible Preferred Stock, an estimated $251M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Allianz Asset Management opened a new position in The Southern Company worth $204M.
- Allianz Asset Management's largest Q2 2022 buy was The Southern Company: 3,850,000 shares worth $204M.
- Allianz Asset Management added most to Exelon in Q2 2022, an estimated $348M increase.
- Allianz Asset Management's biggest Q2 2022 reduction was NVIDIA, cutting an estimated $373M.
- Allianz Asset Management fully exited Avantor, Inc. Series A Mandatory Convertible Preferred Stock in Q2 2022, selling an estimated $251M.
- Allianz Asset Management's ten largest holdings make up 17% of its $105B portfolio in Q2 2022.
- Allianz Asset Management opened 149 new positions and closed 294 in Q2 2022.
- Allianz Asset Management's portfolio value fell 22% quarter-over-quarter to $105B.
Based on Allianz Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.